Evidence map›Paper›PMID 34791258›Full record

Observational studyThe International journal of pharmacy practice2022

Coronavirus disease patients' views and experiences of pharmaceutical care services in Lebanon.

Tareq L Mukattash, Anan S Jarab, Walid Al-Qerem, Rana K Abu Farha, Rania Itani, Samar Karout, Ibrahim L Mukattash

Abstract readObservational Study
In one paragraph

Observational study in The International journal of pharmacy practice, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Upscaling the pharmacy profession: Knowledge and willingness of the Lebanese pharmacists to practice the administration of dermal fillers.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2022
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tareq L MukattashDepartment of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan.ORCID 0000-0003-0200-9845
Anan S JarabDepartment of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan.ORCID 0000-0002-0416-506X
Walid Al-QeremDepartment of Pharmacy, Faculty of Pharmacy, Al-Zaytoonah University of Jordan, Amman, Jordan.
Rana K Abu FarhaDepartment of Therapeutics and Clinical Pharmacy, Faculty of Pharmacy, Applied Science Private University, Amman, Jordan.
Rania ItaniPharmacy Practice Department, Faculty of Pharmacy, Beirut Arab University, Beirut, Lebanon.ORCID 0000-0003-4316-3224
Samar KaroutPharmacy Practice Department, Faculty of Pharmacy, Beirut Arab University, Beirut, Lebanon.
Ibrahim L MukattashDepartment of Marketing, Faculty of Business, Applied Science Private University, Amman, Jordan.

Funding

Deanship of Research at the Jordan University of Science and Technology 20210061Jordan University of Science and Technology 20210061
6 · The paper itself

Abstract

objectivesThis study aimed to explore the experiences and views of domiciliary coronavirus disease (COVID-19) patients towards pharmaceutical care services provided during their infection.

methodsThis was a single-centred observational study conducted among home-treated COVID-19 patients (n = 500), who were tested positive for COVID-19 in a medical centre in Lebanon. KEY

findingsOut of the 500 home-treated COVID-19 patients invited to participate in the study, 279 patients completed the questionnaire. Although the participants had a good view of pharmacists caring for COVID-19 patients (mean view score: 17.79/25), their treatment experiences were unsatisfactory (mean experience score: 1.51/4).

conclusionsCOVID-19 patients reported minimal involvement of pharmacists in their treatment. Therefore, in response to the COVID-19 pandemic, healthcare authorities should intervene in restructuring, guiding and reviewing unrealized new pharmaceutical services to COVID-19 outpatients.

Indexed as

Community Pharmacy ServicesCOVID-19Pharmaceutical ServicesHumansLebanonPandemicsPharmacistsProfessional RoleSARS-CoV-2community pharmacistsCOVID-19perceptionpharmaceutical care

Identifiers

PMID34791258
PMCPMC8767875

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.